z-logo
open-access-imgOpen Access
Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia
Author(s) -
Constantine E. Kosmas,
Maria D. Bousvarou,
Andreas Sourlas,
E Papakonstantinou,
Edilberto Peña Genao,
Rogers Echavarria Uceta,
Eliscer Guzman
Publication year - 2022
Publication title -
clinical pharmacology advances and applications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.685
H-Index - 27
ISSN - 1179-1438
DOI - 10.2147/cpaa.s345072
Subject(s) - pcsk9 , ezetimibe , medicine , pharmacology , lipoprotein lipase , microsomal triglyceride transfer protein , endocrinology , proprotein convertase , cholesterol , lipoprotein , very low density lipoprotein , ldl receptor , adipose tissue

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom